Back to overview

Funding characteristics of randomised clinical trials supported by the Swiss National Science Foundation: a retrospective cohort study

Type of publication Peer-reviewed
Publikationsform Original article (peer-reviewed)
Author AmstutzAlain, SchandelmaierStefan, FreiRoy, AgarwalArnav, AlturkiReem, Von NiederhäusernBelinda, Von ElmErik, BrielMatthias,
Project Supporting Lesotho on the way towards the UNAIDS 90-90-90 targets: Operational and clinical research addressing HIV/AIDS care in resource-limited settings
Show all

Original article (peer-reviewed)

Journal Swiss Medical Weekly
Volume (Issue) 148(34)
Page(s) N/A
Title of proceedings Swiss Medical Weekly
DOI 10.4414/smw.2018.14587

Open Access

Type of Open Access Website


AIMS OF THE STUDY Failure to publish publicly funded research represents a waste of scarce research resources across medical disciplines and countries. In Switzerland, about 40% of randomised clinical trials (RCTs) supported by the Swiss National Science Foundation (SNSF) were not published. We aimed to describe funding characteristics of published and unpublished RCTs supported by the SNSF, to quantify the amount of money spent for unpublished studies, and to compare our results to a similar study performed in the UK. METHODS We established a retrospective cohort of RCTs funded by the SNSF up to 2015. For each RCT proposal, two investigators independently identified corresponding publications in electronic databases and trial registries. Teams of two investigators independently extracted details from the original SNSF proposal and, if available, from trial registries or publications. In addition, we surveyed principal investigators about trial costs and additional sources of funding. RESULTS We included 101 RCTs supported by the SNSF between 1986 and 2015. Most were single-centre RCTs with a median of 138 participants (interquartile range [IQR] 76–400). Overall, 67 (67%) principal investigators responded to our main survey questions. Median total costs per RCT were CHF 428 000 (IQR 282 000–900 000) of which the SNSF provided a median CHF 222 000 (67% of total costs, IQR 40–80%). Most investigators (70%) mentioned additional funding, mainly from their own institution or private foundations. A total of CHF 6.7 million was granted to RCTs that remained unpublished. Funding characteristics were similar to publicly funded trials in the UK. CONCLUSIONS A third of the total SNSF grant sum spent on healthcare RCTs between 1986 and 2015 did not result in peer-reviewed scientific publications. New SNSF grant schemes might improve publication outcomes but their effectiveness needs to be evaluated.